As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...

Kennedy is nominated to lead the Department of Health and Human Services, a position that would give him enormous control ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

And remember, Medicare provides access to about 8,000 drugs ... but what I will tell you is there is a core of personnel at HHS, regardless of administration, that has done dramatically important ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...